KM, D., WM, H., AD, S., CM, H., & LA, B. (2022). Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors. The Journal of pathology, 256(2), 143. https://doi.org/10.1002/path.5834
Chicago Style (17th ed.) CitationKM, Dreijerink, Hackeng WM, Singhi AD, Heaphy CM, and Brosens LA. "Clinical Implications of Cell-of-origin Epigenetic Characteristics in Non-functional Pancreatic Neuroendocrine Tumors." The Journal of Pathology 256, no. 2 (2022): 143. https://doi.org/10.1002/path.5834.
MLA (9th ed.) CitationKM, Dreijerink, et al. "Clinical Implications of Cell-of-origin Epigenetic Characteristics in Non-functional Pancreatic Neuroendocrine Tumors." The Journal of Pathology, vol. 256, no. 2, 2022, p. 143, https://doi.org/10.1002/path.5834.